Sigyn Therapeutics, Inc. (SIGY)

Market Cap	85.19K -99.3%
Revenue (ttm)	n/a
Net Income	-3.22M
EPS	-2.01
Shares Out	2.54M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	369,498
Average Volume	255,729
Open	0.0171
Previous Close	0.0248
Day's Range	0.0171 - 0.0372
52-Week Range	0.0112 - 5.0000
Beta	-0.69
RSI	32.31
Earnings Date	Apr 2, 2026

About Sigyn Therapeutics

Sigyn Therapeutics, Inc., a development-stage company, develops and sells medical devices to treat cancer and infectious disease disorders in the United States. Its lead product candidate is Sigyn therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community-acquired pneumonia, drug-resistant bacterial infections, and emerging pandemic threats. The company is also involved in the evaluation of Sig...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: SIGY